癌症診斷市場：按檢測類型、癌症類型、最終用戶和地區分類

Cancer Diagnostics Market, By Test Type, By Cancer Type, By End User, and by Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，癌症診斷市場規模將達到 779.5 億美元，到 2033 年將達到 1,499.7 億美元。預計從 2026 年到 2033 年，該市場將以 9.8% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	779.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.80%	2033年市場規模預測：	1499.7億美元

癌症是一大類疾病，幾乎可以發生在身體的任何器官或組織。當異常細胞不受控制地增殖，侵入超出其原有邊界的鄰近組織或轉移到其他器官時，就會發生癌症。後一種過程稱為“轉移”，是癌症死亡的主要原因。腫瘤和惡性腫瘤也是癌症的常用名稱。用於診斷癌症的腫瘤生物標記檢測包括前列腺特異性抗原 (PSA)、循環性腫瘤細胞(CTC)、胎兒球蛋白(AFP) 檢測、胰腺癌 CA-19 檢測、HER-2 檢測、BRCA 檢測、肺癌 ALK 檢測、癌胚抗原 (CEA) 檢測、EGFR 突變檢測和 RAS 突變檢測。

市場動態

主要市場參與者正致力於採取內部成長策略，例如推出新的癌症診斷方法，這推動了全球癌症診斷市場的成長。例如，2020年3月，醫療技術公司BD（貝克頓·迪金森公司）和美國私人臨床診斷公司BioMedomics宣布推出一種新的即時檢測方法，該方法可以檢測血液中的抗體，並確認患者當前或既往是否接觸過PARP生物標記，且僅需15分鐘即可完成檢測。此外，用於癌症診斷的先進新技術的開發預計也將支持市場成長。 2021年11月，西門子醫療推出了Naeotom Alpha，這是世界上首款光子計數CT掃描儀，其解析度更高，並且在超高解析度掃描中輻射劑量最多可降低45%。因此，由於上述因素，預計該細分市場在不久的將來將呈現成長態勢。

此外，各國政府和其他醫療機構正努力為50至75歲的女性提供乳房X光檢查服務。 2020年6月，美國醫療設備製造商FUJIFILM醫療系統公司宣佈在美國發起一項新的篩檢宣傳宣傳活動，旨在提高人們對乳癌早期發現的認知。這項名為「勇於無畏」（Aspire to Be Fearless）的宣傳活動將派出一輛移動式乳房X光檢查車，在全美各地巡迴宣傳FUJIFILM的訊息。該車將配備候診室、更衣室以及FUJIFILM最新的乳房攝影影像解決方案。

本研究的主要特點：

本報告對全球癌症診斷市場進行了詳細分析，預測了2026年至2033年（以2025年為基準年）的市場規模和複合年成長率。報告也指出了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新測試的推出和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本報告根據以下參數介紹了全球癌症診斷市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
全球癌症診斷市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用各種用於分析全球癌症診斷市場的策略矩陣來簡化決策過程。

公司簡介
- Myriad Genetics, Inc.
- Invitae Corporation
- NeoGenomics Laboratories, Inc.
- BPS Bioscience
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB
- F.Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC（imaware）
- Svar Life Science AB
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- GE Healthcare
- Illumina, Inc.
- Koninklijke Philips NV
- Toshiba Medical Systems Corporation
- Agilent Technologies, Inc.
- Aurora Imaging Technologies, Inc.
- Quest Diagnostics.

第9章

參考
調查方法

簡介目錄

Product Code: CMI4029

Cancer Diagnostics Market is estimated to be valued at USD 77.95 Bn in 2026 and is expected to reach USD 149.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 77.95 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.80%	2033 Value Projection:	USD 149.97 Bn

Cancer is a large group of diseases that can start in almost any organ or tissue of the body when abnormal cells grow uncontrollably, go beyond their usual boundaries to invade adjoining parts of the body, and/or spread to other organs. The latter process is called metastasizing and is a major cause of death from cancer. A neoplasm and malignant tumor are other common names for cancer. Tumor biomarkers test used in the diagnosis of cancer include, prostate-specific antigen (PSA), circulating tumor cells (CTC), Alfa-fetoprotein test (AFP), CA-19 test for pancreatic cancer, HER-2 test, BRCA test, ALK test for lung cancer, carcinoembryonic test (CEA), EGFR mutation test, and RAS mutation test.

Market Dynamics

The key market players are focusing on the adoption of growth organic strategies such as launching new cancer diagnostics, which is attributed to the growth of the global cancer diagnostics market. For instance, in March 2020, BD (Becton, Dickinson and Company) a medical technology company, and BioMedomics, a privately held, U.S.-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to PARP biomarker test in as little as 15 minutes. Furthermore, the development of new technologically advanced products for cancer diagnosis is expected to support market growth. In November 2021, Siemens Healthineers launched Naeotom Alpha, the globe's first photon-counting CT Scannerwith improved resolution as well as a reduction in radiation dose by up to 45% for ultra-high resolution scans. Thus, the segment is expected to show growth in the near future due to the above-mentioned factors.

Furthermore, governments and other healthcare organizations are taking initiatives to provide women between 50 to 75 years access to mammography screening. In June 2020, Fujifilm Medical Systems is Medical equipment manufacturer in the U.S.A. announced a new breast cancer screening awareness campaign focused on early detection of the disease in the United States. The 'Aspire to Be Fearless' campaign involves a mobile mammography vehicle traveling throughout the United States to spread Fujifilm's message. The vehicle includes a waiting room, dressing room, and the latest breast imaging solutions from Fujifilm.

Key features of the study:

This report provides an in-depth analysis of the global cancer diagnostics market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period 2026-2033, considering 2025 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new test launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cancer diagnostics market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Myriad Genetics, Inc., F. Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., and BPS Bioscience, Inc. Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, Abbott Laboratories, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Aurora Imaging Technologies, Inc., and Quest Diagnostics.
Global cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer diagnostics market.

Detailed Segmentation:

Global Cancer Diagnostics Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Tumor Biomarkers Tests
Imaging
Biopsy
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
Global Cancer Diagnostics Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
Global Cancer Diagnostics Market, By End User (Revenue, USD Bn, 2021 - 2033)
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
Global Cancer Diagnostics, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Myriad Genetics, Inc
F. Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Antibodies Inc.
Networks LLC
Beckman Coulter, Inc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare GmbH
Bio Rad Laboratories Inc.
Exagen Inc.
Genway Biotech, Inc.
Microdrop LLC (imaware)
Svar Life Science AB
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
GE Healthcare
Illumina, Inc.
Koninklijke Philips N.V.
Toshiba Medical Systems Corporation
Agilent Technologies, Inc.
Aurora Imaging Technologies, Inc.
Quest Diagnostics.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Cancer Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Cancer Diagnostics Market, By Test Type, 2021 - 2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Tumor Biomarkers Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - PSA Tests
  - CTC Tests
  - AFP Tests
  - CA-19 Tests
  - HER2 Tests
  - BRCA Tests
  - ALK Tests
  - CEA Tests
  - EGFR Mutation Tests
  - KRAS Mutation Tests
  - Others
Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - Ultrasound
  - Mammography
  - MRI Scan
  - PET Scan
  - CT Scan
Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - Needle Biopsy
  - Endoscopic Biopsy
  - Bone Marrow Biopsy
  - Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization

5. Global Cancer Diagnostics Market, By Cancer Type 2021 - 2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Blood Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Stomach Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Cancer Diagnostics Market, By End User 2021 - 2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Associated Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Independent Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Cancer Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Cancer Diagnostics Market, By Regions, 2021 - 2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 - 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Myriad Genetics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Invitae Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- NeoGenomics Laboratories, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- BPS Bioscience
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Antibodies Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Networks LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Beckman Coulter, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Euro Diagnostica AB
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- F.Hoffmann-La Roche Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Qiagen NV
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Siemens Healthcare GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Augurex Life Sciences Corp.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bio Rad Laboratories Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Exagen Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genway Biotech, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Microdrop LLC (imaware)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Svar Life Science AB
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bio Rad Laboratories Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- GE Healthcare
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Illumina, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Koninklijke Philips N.V.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Toshiba Medical Systems Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Agilent Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aurora Imaging Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Quest Diagnostics.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies